EyePoint Pharmaceuticals’ (EYPT) said Monday the US Department of Veteran Affairs will allow its eye treatments Dexycu and Yutiq to be included on the Federal Supply Schedule, giving veterans and other federal government agencies access to both products.

Shares rose 5% in morning trade.

According to a statement, the VA FSS contract will extend access to Eyepoint products to over nine million VA beneficiaries, along with others within the US federal system.

The final VA contract is expected to have a five-year term and executed in the following months.